{
    "_id": "27267267|None",
    "id": "27267267",
    "infons": {},
    "passages": [
        {
            "infons": {
                "journal": "Hum Gene Ther Clin Dev. 2016 Jun;27(2):57-61. doi: 10.1089/humc.2016.29010.ind. ",
                "year": "2016",
                "type": "title",
                "authors": "Schimmer J, Breazzano S"
            },
            "offset": 0,
            "text": "Investor Outlook: Rising from the Ashes; GSK's European Approval of Strimvelis for ADA-SCID.",
            "sentences": [],
            "annotations": [
                {
                    "id": "3",
                    "infons": {
                        "identifier": "-",
                        "type": "Chemical",
                        "valid": false,
                        "normalized_id": null,
                        "biotype": "chemical"
                    },
                    "text": "Rising",
                    "locations": [
                        {
                            "offset": 18,
                            "length": 6
                        }
                    ]
                },
                {
                    "id": "4",
                    "infons": {
                        "identifier": "-",
                        "type": "Chemical",
                        "valid": false,
                        "normalized_id": null,
                        "biotype": "chemical"
                    },
                    "text": "Strimvelis",
                    "locations": [
                        {
                            "offset": 68,
                            "length": 10
                        }
                    ]
                },
                {
                    "id": "5",
                    "infons": {
                        "identifier": "MESH:C531816",
                        "type": "Disease",
                        "valid": true,
                        "normalized": [
                            "C531816"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "C531816",
                        "biotype": "disease",
                        "name": "Severe combined immunodeficiency due to adenosine deaminase deficiency",
                        "accession": "@DISEASE_Severe_combined_immunodeficiency_due_to_adenosine_deaminase_deficiency"
                    },
                    "text": "ADA-SCID",
                    "locations": [
                        {
                            "offset": 83,
                            "length": 8
                        }
                    ]
                }
            ],
            "relations": []
        },
        {
            "infons": {
                "type": "abstract"
            },
            "offset": 93,
            "text": "GlaxoSmithKline's (GSK) and partner San Raffaele Telethon Institute for Gene Therapy's recent positive European approval for Strimvelis for treatment of severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID) represents the second EU-approved gene therapy and the first gamma-retrovirus and first ex vivo gene therapy. In this article we discuss the significance and implications of this historic approval for the broader gene therapy field.",
            "sentences": [],
            "annotations": [
                {
                    "id": "11",
                    "infons": {
                        "identifier": "-",
                        "type": "Chemical",
                        "valid": false,
                        "normalized_id": null,
                        "biotype": "chemical"
                    },
                    "text": "Strimvelis",
                    "locations": [
                        {
                            "offset": 218,
                            "length": 10
                        }
                    ]
                },
                {
                    "id": "12",
                    "infons": {
                        "identifier": "MESH:D016511",
                        "type": "Disease",
                        "valid": true,
                        "normalized": [
                            "D016511"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "D016511",
                        "biotype": "disease",
                        "name": "Severe Combined Immunodeficiency",
                        "accession": "@DISEASE_Severe_Combined_Immunodeficiency"
                    },
                    "text": "severe combined immunodeficiency",
                    "locations": [
                        {
                            "offset": 246,
                            "length": 32
                        }
                    ]
                },
                {
                    "id": "13",
                    "infons": {
                        "identifier": "MESH:C531816",
                        "type": "Disease",
                        "valid": true,
                        "normalized": [
                            "C531816"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "C531816",
                        "biotype": "disease",
                        "name": "Severe combined immunodeficiency due to adenosine deaminase deficiency",
                        "accession": "@DISEASE_Severe_combined_immunodeficiency_due_to_adenosine_deaminase_deficiency"
                    },
                    "text": "adenosine deaminase deficiency",
                    "locations": [
                        {
                            "offset": 286,
                            "length": 30
                        }
                    ]
                },
                {
                    "id": "14",
                    "infons": {
                        "identifier": "MESH:C531816",
                        "type": "Disease",
                        "valid": true,
                        "normalized": [
                            "C531816"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "C531816",
                        "biotype": "disease",
                        "name": "Severe combined immunodeficiency due to adenosine deaminase deficiency",
                        "accession": "@DISEASE_Severe_combined_immunodeficiency_due_to_adenosine_deaminase_deficiency"
                    },
                    "text": "ADA-SCID",
                    "locations": [
                        {
                            "offset": 318,
                            "length": 8
                        }
                    ]
                },
                {
                    "id": "15",
                    "infons": {
                        "identifier": "153135",
                        "type": "Species",
                        "valid": true,
                        "normalized": [
                            153135
                        ],
                        "database": "ncbi_taxonomy",
                        "normalized_id": 153135,
                        "biotype": "species",
                        "name": "153135",
                        "accession": null
                    },
                    "text": "gamma-retrovirus",
                    "locations": [
                        {
                            "offset": 389,
                            "length": 16
                        }
                    ]
                }
            ],
            "relations": []
        }
    ],
    "relations": [],
    "pmid": 27267267,
    "pmcid": null,
    "meta": {},
    "date": "2016-06-01T00:00:00Z",
    "journal": "Hum Gene Ther Clin Dev",
    "authors": [
        "Schimmer J",
        "Breazzano S"
    ],
    "relations_display": []
}